森西林 | 22164-94-9

• 物质功能分类: 原料药 - 抗生素类药物 - 青霉素类药
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 森西林
• 英文名称: Suncillin
• 英文别名: (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-phenyl-2-(sulfoamino)acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
• CAS: 22164-94-9
• 化学式: C₁₆H₁₉N₃O₇S₂
• 分子量: 429.5
• InChiKey: OIECDSKSPRTZHG-NJBDSQKTSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  28
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  187
• 氢给体数：
  4
• 氢受体数：
  9

文献信息

• Diagnostic/therapeutic agents
  申请人：Klaveness Jo

  公开号：US20050002865A1

  公开（公告）日：2005-01-06

  Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, comprising a suspension in an aqueous carrier liquid of a reporter comprising gas-containing or gas-generating material, said agent being capable of forming at least two types of binding pairs with a target.

  可定位的诊断和/或治疗活性剂，例如超声对比剂，包括悬浮在水载体液中的报告物，该报告物包含含气体或生成气体的材料，该剂能够与目标形成至少两种结合对。
• Carbapenem derivatives, a process for their preparation and pharmaceutical compositions containing them
  申请人：BEECHAM GROUP PLC

  公开号：EP0005348A1

  公开（公告）日：1979-11-14

  This invention provides the antibacterial compounds of the formula (I): and salts and cleavable esters thereof wherein X is a SCH2CH2NH2 or Y NH.CO.CH3 group where Y is a SCH2CH2 trans -SO-CH=CH- or cis or trans -S-CH=CH- group and R is a lower alkyl, aryl, aralkyl, lower alkenyl or substituted lower alkyl group. The invention also relates to processes for the preparation of the said compounds and pharmaceutical compositions containing them.

  本发明提供了式(I)的抗菌化合物： 及其盐和可裂解酯 其中 X 是 SCH2CH2NH2 或 Y NH.CO.CH3 基团，其中 Y 是 SCH2CH2 反式 -SO-CH=CH- 或顺式或反式 -S-CH=CH- 基团，R 是低级烷基、芳基、芳烷基、低级烯基或取代的低级烷基。 本发明还涉及上述化合物的制备工艺和含有这些化合物的药物组合物。
• Alkylcarbapenems, their preparation, use in pharmaceutical compositions and intermediates
  申请人：BEECHAM GROUP PLC

  公开号：EP0005349A1

  公开（公告）日：1979-11-14

  This invention provides the antibacterial compounds of the formula (I): and salts and cleavable esters thereof wherein A is a C=CH-CH3 or CH-CH2-CH3 group and Y is a -S-CH2CH2-, -S-CH = CH- or -SO-CH = CH- group. The invention also relates to process for the preparation of the said compounds and pharmaceutical compositions containing them.

  本发明提供了式(I)的抗菌化合物： 及其盐和可裂解酯，其中 A 是 C=CH-CH3 或 CH-CH2-CH3 基团，Y 是 -S-CH2CH2-、-S-CH = CH- 或 -SO-CH = CH- 基团。 本发明还涉及上述化合物的制备工艺和含有这些化合物的药物组合物。
• Beta-lactam antibiotics, their preparation, pharmaceutical compositions containing them and their preparation
  申请人：BEECHAM GROUP PLC

  公开号：EP0024832A1

  公开（公告）日：1981-03-11

  The compounds of the formula: and pharmaceutically acceptable salts and in-vivo hydrolysable esters thereof wherein R' is a hydrogen atom or a group selected from OH, OSO3H or a pharmaceutically acceptable salt or C1-4 alkyl ester thereof, OR2, SR3, OCOR2, OCO2R3 or OCONHR3, where R2 is a C1-6 alkyl group or an optionally substituted benzyl group and R3 is a C1-6 alkyl group or an optionally substituted benzyl or an optionally substituted phenyl group; and R22 is a hydrogen atom, C1-6 alkyl, C2-6 alkenyl, C3-6 alkynyl wherein the triple bond is not present on the carbon adjacent to the sulphur atom, aralkyl, C1-6 alkanoyl, aralkanoyl, aryloxyalkanoyl or arylcarbonyl, any of such R22 groups being optionally substituted; with the proviso that when R22 is 2-aminoethyl R' must be SR3 or OSOaH or a pharmaceutically acceptable salt or C1-4 alkyl ester thereof; have been found to be antibacterially active. Their use is described as are processes for their preparation.

  式中的化合物： 及其药学上可接受的盐和体内可水解的酯 其中 R' 是氢原子或选自 OH、OSO3H 或其药学上可接受的盐或 C1-4 烷基酯、OR2、SR3、OCOR2、OCO2R3 或 OCONHR3 的基团，其中 R2 是 C1-6 烷基或任选取代的苄基，R3 是 C1-6 烷基或任选取代的苄基或任选取代的苯基；R22是氢原子、C1-6烷基、C2-6烯基、C3-6炔基（其中与硫原子相邻的碳上不存在三键）、芳烷基、C1-6烷酰基、芳烷酰基、芳氧基烷酰基或芳羰基，其中任何一个R22基团均可任选取代；但当R22是2-氨基乙基时，R'必须是SR3或OSOaH或其药学上可接受的盐或C1-4烷基酯。本文介绍了它们的用途及其制备工艺。
• Process for the preparation of 2-thio penem derivatives and intermediates therefor
  申请人：BEECHAM GROUP PLC

  公开号：EP0046363A1

  公开（公告）日：1982-02-24

  The present invention provides a process for the preparation of a compound of the formula (IV): or salt or ester thereof wherein R1 and R2 are independently hydrogen; an organic radical bonded via a carbon atom to the ring carbon atom; a free, etherified or esterified hydroxy or mercapto group; an amino or acylamino group; or together R1 and R2 represent a group = CR5R6 wherein R5 and R6 are the same or different and each represent hydrogen or a hydrocarbon or heterocyclic group optionally substituted with a functional group; and R3 represents an organic radical; which process comprises reacting a compound of the formula (V): wherein Rx is hydrogen or a blocking group and R4 is an organic radical; with a thiol or reactive derivative thereof. The compounds of the formula (IV) are useful as antibiotics and [β-lactamase inhibitors, as are the compounds of the formula (V). This invention also provides the novel compounds of the formula (V) and certain novel compounds within formula (IV). Their preparation and use are described.

  本发明提供了一种制备式(IV)化合物或其盐或酯的工艺： 或其盐或酯 其中 R1 和 R2 独立地为氢；通过碳原子与环碳原子键合的有机基；游离的、醚化的或酯化的羟基或巯基；氨基或酰氨基；或 R1 和 R2 共同代表一个基团＝CR5R6 其中 R5 和 R6 相同或不同，且各自代表氢或任选被官能团取代的烃基或杂环基；以及 R3 代表有机基；该工艺包括使式(V)： 其中 Rx 是氢或封端基团，R4 是有机基团；与硫醇或其反应衍生物反应。式（IV）化合物可用作抗生素和[β-内酰胺酶抑制剂]，式（V）化合物也可用作抗生素和[β-内酰胺酶抑制剂]。本发明还提供了新型的式 (V) 化合物和某些新型的式 (IV) 化合物。对它们的制备和用途进行了描述。